Publications & Presentations

SELECTED SPEAKING ENGAGEMENTS

  • Cornell University Medical College, Medical Foods, A Case Study.
  • Michael J. Fox Foundation, Evaluation of neuroprotective ability of Zymes’ water-soluble CoQ10 in animal models of PD: preclinical validation and dose optimization for clinical study.
  • Overlook Hospital psychiatric outpatient clinic, Food and Mood
  • Michael J. Fox Foundation, Progress report: Evaluation of neuroprotective ability of Zymes’ water-soluble CoQ10 in animal models of PD: preclinical validation and dose optimization for clinical study.
  • Gerontology Society of America, Inhibition of premature senescence of fibroblast cells from Alzheimer’s Disease Patients by water-soluble coenzyme Q10.
  • Experimental Biology, Protection of SNpc neurons by water soluble CoQ10 in paraquat-induced rat model of Parkinson’s disease: the role of neurotrophic factors.
  • Invited speaker, NJ Technology Center Forum on Nanotechnology in Foods, Drugs and Cosmetics.
  • Invited speaker, 12 Annual Drug Delivery Technologies and Deal Making, New Brunswick, NJ.

RECENT CONFERENCES ATTENDED

  • American Society for Nutrition, online, 2020
  • American College of Nutrition, online, 2020
  • Obesity: Etiology, Prevention and Treatment, New York, NY, 2017, 2018, 2019
  • Personalized Nutrition: Translating the Science of NutriGenomics into Practice, Seattle, WA 2018
  • The 14th US-Japan Symposium on Drug Delivery Systems, Maui, Hawaii, 2017
  • Disrupting Cancer: The Role of Personalized Nutrition, Alexandria, VA, October 2017
  • Institute of Functional Medicine, Applying Functional Medicine in Clinical Practice, June 2017
  • Micronutrient Forum Global Conference, ‘Positioning Women’s Nutrition at the Centre of Sustainable Development, Cancun, Mexico 2016
  • American College of Nutrition, “Translational Nutrition: Optimizing Brain Health, Orlando, FL, 2015
  • NutritionPro, Medical Nutrition Therapy in Practice, Orlando, FL 2015
  • American College of Nutrition, “Turning Research into Practice”, San Antonio, TX 2014
  • American College of Nutrition, “Controversies in Nutrition”, San Diego, CA 2013
  • Assessing Malnutrition Globally, NYC 2013
  • American Society of Nutrition, Boston, April 2013
  • American College of Nutrition, “Overfed and Undernourished”, November 2012
  • New York Academy of Sciences, Sixth Annual Parkinson’s Disease Therapeutic Conference, October 2012
  • Healthy Kitchens, Healthy Lives, Culinary Institute of American and Harvard Medical School, March 2010
  • AAFP – Nutrition and Heart Disease, May 2010

SELECTED PUBLICATIONS

  • Anselmo AC, Xu X, Burkli S, Zeng YY, Tang W, McHugh KJ, Behrens AM, Rosenberg E, Duan A, Sugarman JL, Zhuang J, Collins J, Lu X, Graf T, Tzeng S, Rose S, Nguyen T, Le X, Guerra AS, Freed LE, Weinstock S, Sears C, Nikolic B, Wood L, Oxley J, Moretti D, Zimmermann M, Langer R, Jaklenec A heat-stable microparticle platform for oral micronutrient delivery.  Sci. Transl. Med. 2019; 11(518), eaaw368.
  • Muthukumaran K, Leahy S,  Harrison K,  Sikorska, S,  Sandhu, JK, Cohen, J,  Keshan C,   Lopatin D,   Miller H,  Borowy-Borowski H,   Lanthier P, Weinstock S,   Pandey  Orally delivered water-soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease.  BMC Neuroscience 2014; 15(1):21.
  • Lee, KY, Bae, ON, Weinstock S, Kassab M, Majid A. Neuroprotective effect of Asiatic acid in rat model of focal embolic stroke.  Biol Pharm Bull. 2014;37(8):1397-401.
  • Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, Keshan C, Lopatin D, Miller H, Borowy-Borowski H, Lanthier P, Weinstock S, Pandey S Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease. BMC Neurosci. 2014 Jan 31;15:21.
  • Cherry CL, Mobarok M, Wesselingh SL, Fain R, Weinstock S, Tachedjian G, Srivastava S, Tyssen DP, Glass JD, Hooker DJ. Coenzyme Q10 is Superior to Acetyl-L-Carnitine for Preventing NRTI-Associated Toxic Neuropathy in an in vitro Curr HIV Res. 2010 Apr;8(3):232-9.
  • Beach, MC, Morley, J, Spiryda, L and Weinstock, SB. “Effects of liposome encapsulated hemoglobin on the reticuloendothelial system.” Biomaterials, Artificial Cells, and Immobilization Biotechnology Journal 20: 2-4, 1992.
  • Bottalico, L, Betensky, HT, Min, YB, and Weinstock, SB. “Perfluorochemical emulsions decrease Kupffer cell phagocytosis.” Hepatology 14: 169-174, 1991.
  • Betensky, HT and Weinstock, SB. “Effects of Fluosol-DA on 51Cr-Sheep red blood cells clearance in the rat in vivo and in the isolated perfused liver.” Artificial Organs 14(3): 208-210, 1990.
  • Weinstock, SB, and Bottalico, L. “Effects of perfluorochemical emulsion on particle clearance in the isolated perfused rat liver.” In: Blood Substitutes. Chang, TMS, and Geyer, RP, eds. Marcel Dekker, NY, 687-689, 1989.
  • Weinstock, SB, and Brain, JD. “Comparison of particle clearance and macrophage phagosomal motion in liver and lungs of rats.” Appl. Physiol. 65(4): 1811-1820, 1988.
  • Weinstock, SB, and Beck, B. “Effects of age and nutrition on non-neoplastic lung disease.” In: Variations in Susceptibility to Toxic Agents in the Air:  Identification, Mechanisms and Policy Implications. Brain, JD, Beck, B, Warren, J, and Shaikh, R, eds. Johns Hopkins Press, Baltimore, MD, 104-126, 1988.
  • Beck, B. and Weinstock, SB. “Effects of gender on non-neoplastic lung disease.” In: Variations in Susceptibility to Toxic Agents in the Air: Identification, Mechanisms and Policy Implications. Brain, JD, Beck, B, Warren, J, and Shaikh, R, eds. Johns Hopkins Press, Baltimore, MD, 127-141, 1988.
  • Warren, J, and Weinstock, SB. “Effects of aging on neoplastic lung disease.” In: Variations in Susceptibility to Toxic Agents in the Air: Identification, Mechanisms and Policy Implications. Brain, JD, Beck, B, Warren, J, and Shaikh, R, eds. Johns Hopkins Press, Baltimore, MD, 253-268, 1988.
  • Weinstock, SB, Brain, JD, and Geyer, RP. “Measurements of phagosomal motion by non-invasive magnetometry in Kupffer cells of rats treated with perfluorochemicals.” In: Cells of the Hepatic Sinusoid, Vol. 1, Kupffer Cell Foundation, The Netherlands, 33-34, 1986.
  • Weinstock, SB, Kopito, RR, Tomera, JF, Marnier, E, Murray, DM, and Brunengraber, H. “The shunt pathway of mevalonate metabolism in the isolated perfused rat liver.” Biol. Chem. 259 (14): 8939-8944, 1984.
  • Kopito, RR, Weinstock, SB, Freed, LE, Murray, DM, and Brunengraber, H. “Metabolism of plasma mevalonate in rats and humans.” Lipid Res. 23: 577-583, 1982.
  • Brunengraber, H, Weinstock, SB, Story, DL, and Kopito, RR. “Urinary clearance and metabolism of mevalonate by the isolated perfused rat kidney.” Lipid Res. 22: 916-920, 1981.
  • Weinstock, SB, Brunengraber, H, Imamura, T. “ Effect of insulin on lipogenesis and glycolysis in the perfused rat lung.” The Pharmacologist 22: 202, 1980.